Stock screenerAll disclosures →
EDGAR →
UTHR
Conviction 35HealthcareScan · Mon, Jul 20, 2026UTHR$529.60-1.13%
ResistanceSupportVol 14Insider sellCongress buyCongress sell18
21
9
Vol MA14 397.18K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price529.60
Change-1.13%
Gap-0.33%
Rel volume0.74×
Avg volume468.41K
Avg $ vol254.47M
SMA 20543.08
SMA 50552.44
SMA 200510.79
Price vs 50-4.14%
Price vs 200+3.68%
MA stackmixed
50/200 cross—
Supertrenddown · 568.20
RSI (14)41
MACD hist-1.53
MACD crossbear · 4d
Stoch %K / %D22 / 26
ADX (14)19
+DI / −DI14 / 21
RSI divergence—
MACD divergence—
ATR %+2.46%
ADR %2.25%
52w high596.76
52w low274.70
From 52w high-11.25%
Above 52w low+92.79%
New 52w highNo
SqueezeFired
Bollinger width7.02%
%B0.15
Donchian pos21.87%
Donchian high563.70
Donchian low520.05
AVWAP (52w high)553.35
vs AVWAP high-4.29%
AVWAP (52w low)470.78
vs AVWAP low+12.49%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d0.74×
Avg vol (14d)397.18K
Avg vol (20d)468.41K
Avg $ vol (20d)254.47M
Market cap22.48B
RS 3m (vs SPY)-13.66%
RS 6m (vs SPY)+4.93%
RS line new highNo
Trend template6/8
Technical rank54.0
1 week-1.12%
1 month-3.97%
3 months-9.99%
6 months+12.20%
1 year+78.12%
YTD+6.62%
P/E16.84
P/B3.81
P/S7.06
P/FCF21.60
EPS27.86
Div yield—
ROE22.62%
ROA19.88%
Debt/Eq—
Current4.79
EV/EBITDA13.43
Gross margin87.92%
Net margin41.94%
Rev growth10.61%
EPS growth11.68%
Price target663.13
Target upside25.21%
Analyst ratingBuy
Institutional109.76%
Ent. value21.2B
Revenue781.5M
Net income274.9M
Gross profit648.1M
Free cash flow1.04B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out42.45M
Employees1.4K
ListedThu, Jun 17, 1999
Free float41.69M
Float %96.8%
Short interest2.12M
Days to cover2.9d
Short volume49.5%
Squeeze score31 / 100
Next earnings—
EPS forecast—
Last EPS vs est$5.82 vs $6.73
Last surprise-13.5% miss
Setup gradeD
Conviction35 / 100
Pattern quality—
Tech rank54.0 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance572.05
Support526.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in UTHR · 3 recent
Insider activity
SEC Form 4 transactions in UTHR · 1 buy · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ROTHBLATT MARTINE A Chairperson & CEO · Stock Option · 2026-07-16 | Exercise | 9.5K | — | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Exercise | 9.5K | $1.3M | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 80 | $42K | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 1.4K | $740K | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 3.06K | $1.6M | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 1.92K | $1.0M | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 520 | $277K | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 440 | $235K | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 1.2K | $640K | 2026-07-16 | 2026-07-17 |
ROTHBLATT MARTINE A Chairperson & CEO · Common Stock · 2026-07-16 | Sell | 720 | $385K | 2026-07-16 | 2026-07-17 |
SEC filings
EDGAR filings in UTHR · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.